huATN-658

huATN -658 is a novel antibody against a target in the urokinase plasminogen activator system. This system plays a central role in multiple pathways and processes related to tumor growth, metastasis, and angiogenesis (the growth of new blood vessels that feed tumors). huATN -658 was humanized by XOMA (US) LLC using their patented Human Engineering (TM) Technology and is currently in preclinical development.